Systems modeling of metabolic dysregulation in neurodegenerative diseases.

Neurodegenerative diseases, Metabolic modeling, Multiomics analysis, Network approaches

Journal

Current opinion in pharmacology
ISSN: 1471-4973
Titre abrégé: Curr Opin Pharmacol
Pays: England
ID NLM: 100966133

Informations de publication

Date de publication:
10 2021
Historique:
received: 25 05 2021
accepted: 28 06 2021
pubmed: 6 8 2021
medline: 9 11 2021
entrez: 5 8 2021
Statut: ppublish

Résumé

Neurodegenerative diseases (NDDs) encompass a wide range of conditions that arise owing to progressive degeneration and the ultimate loss of nerve cells in the brain and peripheral nervous system. NDDs such as Alzheimer's, Parkinson's, and Huntington's diseases negatively impact both length and quality of life, due to lack of effective disease-modifying treatments. Herein, we review the use of genome-scale metabolic models, network-based approaches, and integration with multiomics data to identify key biological processes that characterize NDDs. We describe powerful systems biology approaches for modeling NDD pathophysiology by leveraging in silico models that are informed by patient-derived multiomics data. These approaches can enable mechanistic insights into NDD-specific metabolic dysregulations that can be leveraged to identify potential metabolic markers of disease and predisease states.

Identifiants

pubmed: 34352486
pii: S1471-4892(21)00085-0
doi: 10.1016/j.coph.2021.06.012
pmc: PMC8511060
mid: NIHMS1729964
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Subventions

Organisme : NIA NIH HHS
ID : RF1 AG058469
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG061835
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG063068
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG059319
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061796
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG046139
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG061359
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062514
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057452
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement Nothing declared.

Références

Nat Rev Drug Discov. 2019 Jun;18(6):463-477
pubmed: 30976107
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1132-1146
pubmed: 27345267
Biotechnol J. 2020 Oct;15(10):e1900519
pubmed: 32744423
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
Mol Psychiatry. 2010 May;15(5):463-72
pubmed: 18936756
Cell Metab. 2018 Jun 05;27(6):1176-1199
pubmed: 29874566
BMC Bioinformatics. 2019 Oct 11;20(1):494
pubmed: 31604427
Nat Biotechnol. 2010 Dec;28(12):1279-85
pubmed: 21102456
Gut Microbes. 2020;11(2):135-157
pubmed: 31368397
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982
pubmed: 32075919
Cell Rep Med. 2020 Nov 17;1(8):100138
pubmed: 33294859
Genes Dev. 2016 Nov 1;30(21):2345-2369
pubmed: 27881599
BMC Syst Biol. 2012 Dec 13;6:153
pubmed: 23234303
Nat Commun. 2018 Aug 7;9(1):3121
pubmed: 30087329
Alzheimers Dement. 2019 Jan;15(1):76-92
pubmed: 30337151
Front Aging Neurosci. 2019 Jun 18;11:130
pubmed: 31275138
Genome Biol. 2019 Jun 13;20(1):121
pubmed: 31196170
Cell Rep. 2019 Nov 12;29(7):1767-1777.e8
pubmed: 31722195
Nat Commun. 2020 Nov 10;11(1):5698
pubmed: 33173055
Nat Rev Neurol. 2018 Mar;14(3):133-150
pubmed: 29377008
Front Aging Neurosci. 2017 Feb 13;9:23
pubmed: 28243200
Basic Clin Pharmacol Toxicol. 2018 Sep;123 Suppl 5:56-61
pubmed: 29924904
Mol Syst Biol. 2018 Mar 26;14(3):e7435
pubmed: 29581148
Trends Neurosci. 2020 Dec;43(12):965-979
pubmed: 33127097
Nat Commun. 2020 Aug 7;11(1):3942
pubmed: 32770063
Nat Protoc. 2019 Mar;14(3):639-702
pubmed: 30787451
PLoS One. 2020 Dec 29;15(12):e0240953
pubmed: 33373364
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Methods Mol Biol. 2019;1903:219-237
pubmed: 30547445
Sci Adv. 2021 Jan 6;7(2):
pubmed: 33523961
Alzheimers Dement. 2021 Mar;17(3):327-406
pubmed: 33756057
PLoS Comput Biol. 2019 Apr 15;15(4):e1006867
pubmed: 30986217
Genome Res. 2018 Aug;28(8):1243-1252
pubmed: 29945882
Cell Rep. 2020 Aug 18;32(7):108029
pubmed: 32814038
J Nucl Med. 2018 Nov;59(11):1645-1648
pubmed: 30385641
Mov Disord Clin Pract. 2021 Jan 31;8(3):352-360
pubmed: 33816663
Curr Neuropharmacol. 2018;16(6):664-725
pubmed: 28831921
Psychiatry Res Neuroimaging. 2016 Nov 30;257:39-46
pubmed: 27771555
Ageing Res Rev. 2014 Mar;14:19-30
pubmed: 24503004
J Glob Health. 2020 Dec;10(2):020407
pubmed: 33110572
Nat Neurosci. 2017 Aug;20(8):1052-1061
pubmed: 28628103
Nat Rev Neurol. 2019 Oct;15(10):565-581
pubmed: 31501588
Anal Chem. 2017 Jan 3;89(1):314-341
pubmed: 28105819
Front Neurosci. 2020 Jul 08;14:716
pubmed: 32733199
Cell Syst. 2019 Feb 27;8(2):122-135.e7
pubmed: 30772379
J Neurotrauma. 2015 Feb 15;32(4):209-20
pubmed: 25192426
Nat Commun. 2020 Nov 13;11(1):5781
pubmed: 33188183
Essays Biochem. 2018 Oct 26;62(4):563-574
pubmed: 30315095
BMC Biol. 2020 Jun 9;18(1):62
pubmed: 32517799
PLoS One. 2013 Sep 27;8(9):e74341
pubmed: 24086336
Nat Commun. 2021 Feb 15;12(1):1033
pubmed: 33589615
Nat Med. 2021 May;27(5):871-881
pubmed: 33927414
Hum Mol Genet. 2010 May 15;19(10):2068-78
pubmed: 20167577
NPJ Parkinsons Dis. 2018 Jul 10;4:21
pubmed: 30003140

Auteurs

Priyanka Baloni (P)

Institute for Systems Biology, Seattle, WA, USA.

Cory C Funk (CC)

Institute for Systems Biology, Seattle, WA, USA.

Ben Readhead (B)

Onegevity, a Division of Thorne HealthTech, New York, NY, USA; Arizona State University-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ, USA.

Nathan D Price (ND)

Institute for Systems Biology, Seattle, WA, USA; Onegevity, a Division of Thorne HealthTech, New York, NY, USA. Electronic address: nathan.price@isbscience.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH